Your 25-second video preview has ended.

to continue watching, please Log In or Register:

Log in / Register

Real-World Outcomes With the Hydrus Microstent

  Channels: Glaucoma | Posted 4/7/2017

Cathleen McCabe, MD, joins James Katz, MD, to discuss the Hydrus Microstent (Ivantis). Dr. McCabe describes differences between this device and the iStent Trabecular Micro-Bypass Stent (Glaukos). She shares data from the Hydrus II randomized, controlled, multicenter trial and data that the company has collected on each of its devices implanted outside the United States.

Glaucoma • Glaukos Corporation • Hydrus® Microstent • iStent • Ivantis

8 / 62 Series: CRST Journal Club

More Videos in this Series